SELLAS Life Sciences Group Inc

NASDAQ:SLS  
8.07
+0.24 (+3.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

SELLAS Life Sciences Group Inc Stock, NASDAQ:SLS

7 Times Square, Suite 2503, New York, New York 10036
United States of America
Phone: +1.646.200.5278
Number of Employees: 7

Description

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of immunotherapeutic for cancer indications. The firm's product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.